Objectives: ICU survivors frequently report reduced health-related quality of life, but the relative importance of preillness versus acute illness factors in survivor populations is not well understood. We aimed to explore health-related quality of life trajectories over 12 months following ICU discharge, patterns of improvement, or deterioration over this period, and the relative importance of demographics (age, gender, social deprivation), preexisting health (Functional Comorbidity Index), and acute illness severity (Acute Physiology and Chronic Health Evaluation II score, ventilation days) as determinants of health-related quality of life and relevant patientreported symptoms during the year following ICU discharge. Design: Nested cohort study within a previously published randomized controlled trial. Setting: Two ICUs in Edinburgh, Scotland. When positive effects have been described, they have been limited to HRQoL subdomains at time points that are of uncertain clinical significance (5) (6) (7) (8) (9) (10) .
Given these results, it is reasonable to assume that the interventions tested are ineffective and that greater knowledge of the underlying pathophysiology and the approaches used in future trials should be research priorities. However, it is also possible that the heterogeneous ICU populations included in trials include subgroups of patients that respond differently to interventions. Specifically, some patients may have refractory functional impairments, perhaps as a result of pre-ICU health that cannot be modified. These patients might mask important positive effects in other subpopulations (12, 13) .
The postintensive care syndrome (PICS) conceptualizes the direct effects of critical illness on physical and mental health, but the importance of preexisting illness relative to the acute "hit" of critical illness remains poorly understood. An improved understanding of the determinants of long-term health following critical illness could improve the evaluation of interventions designed to improve recovery. The inclusion of HRQoL as a core outcome following critical illness highlights the need for a detailed understanding of this and related outcome measures (14) .
In a randomized trial of postintensive care hospital-based rehabilitation, we recently found no effect on measures of functional status, HRQoL, or physical symptoms during 12 months follow-up (5, 15) . We hypothesized that this lack of effect might relate in part to precritical illness factors, a "signal to noise" issue, whereby the "noise" of nonmodifiable preexisting health may have dominated any "signal" of effect in the trial. Our aims in this nested cohort study of the trial data were to describe trajectories of HRQoL over 12 months following ICU discharge; to identify patients whose HRQoL either deteriorated or failed to improve between 3 and 12 months ICU discharge; to explore the relative importance of patient demographics, precritical illness health status, and critical illness severity as determinants of individual HRQoL trajectory after ICU discharge; and to assess the consistency of associations in other patient-centered outcomes we collected in the trial.
MATERIALS AND METHODS
This was a cohort study nested within a randomized trial of increased hospital-based physical rehabilitation and information provision for ICU survivors who required greater than or equal to 48 hours of continuous mechanical ventilation (MV). Detailed trial inclusion/exclusion criteria have been published previously (16) . Participants received either usual care or the intervention. As no treatment effects for HRQoL or patient-reported symptoms were found, a single cohort was constructed from the trial database to address the following research questions: What were the cohort level trajectories of Physical Component Score (PCS) and Mental Component Score (MCS) between 3 and 12 months after ICU discharge? What proportions of patients showed no clinically important improvement of PCS and MCS between 3 and 12 months? Which factors were most strongly associated with HRQoL at 6 and 12 months post ICU discharge? Which factors were most strongly associated with patient-reported symptoms at 12 months post ICU discharge? This study was approved by the Scotland A Research Ethics committee. Participants or their surrogate decision makers provided written informed consent.
Outcome Measures
For HRQoL, the Medical Outcomes Study Short Form 12 version 2 (SF12v2), including the PCS (range 0-100) and MCS (range 0-100), calculated using U.S.-derived coefficients (17) . Patient-reported physical symptoms of appetite, fatigue, pain, joint stiffness, and breathlessness were measured on a visual analogue scale of 10 cm in length ranging from 0 (no symptoms at all) to 10 (worse symptoms imaginable). As per the trial protocol, the trial aimed to measure these outcomes for all surviving patients at 3, 6, and 12 months post randomization.
Exposures
We selected variables from the trial database to best represent demographics, preexisting comorbidity burden, and critical illness severity and duration. The number of variables did not exceed recommended maximums to prevent overfitting (18) .
Patient Characteristics. We used age, gender, and social deprivation. Social deprivation was measured using the Scottish Index of Multiple Deprivation (SIMD), a postcode-based deprivation ranking of each of 6,976 geographical areas within Scotland. These are described in quintiles ranging from 1 (most deprived) to 5 (least deprived) (19).
Preexisting Comorbidity Burden. We used the Functional Comorbidity Index (FCI) assessed at study entry by review of medical records and by discussion with patients and families. This validated measure is based on 18 comorbidity items with higher scores indicating more comorbidities (20, 21) .
Features of Acute Illness Severity. We used the Acute Physiology and Chronic Health Evaluation (APACHE) II score (22) and days of MV.
Immediate Post-ICU Discharge Physical Status. We measured the Rivermead Mobility Index (RMI) and the physical assessment of the Subjective Global Assessment (SGA) of Nutrition at enrollment (ICU discharge). The RMI is a hierarchical mobility index ranging from 0 (bedridden) to 15 (able to run) (23) . The SGA is a subjective clinical assessment of nutritional status based on signs of fat loss, muscle wasting, and edema measured on a scale of 1 (well nourished) to 3 (severely malnourished) (24) .
Analysis
Statistical analysis was conducted using SPSS (IBM Corp. 
Proportions of Patients That Showed no Clinically Important Improvement of PCS and MCS Between 3 and 12 Months.
We defined a minimum clinical important difference (MCID) in PCS and MCS as greater than ±5 points (consistent with published literature) and used Sankey plots to illustrate groups of patients that improved, deteriorated, or remained static between 3 and 12 months (25) . To explore floor and ceiling effects in this analysis, we replotted the Sankey plots for each quartile of HRQoL score at baseline.
Factors Most Strongly Associated With HRQoL at 6 and 12 Months After ICU Discharge. We used bivariate unadjusted linear regression to examine univariate associations between the exposure variables and HRQoL at 6 and 12 months following ICU discharge and multivariable linear models to explore the relative importance of each variable. For each outcome variable, two models were fitted. The first model excluded physical status measured at ICU discharge (SGA and RMI at ICU discharge; model 1) on the assumption that these variables encompassed the effects of the acute illness and the premorbid physical function and would not add additional information. As a sensitivity analysis, the second model (model 2) included the RMI and SGA nutrition at ICU discharge to explore the possibility that immediate post-ICU physical status might more strongly account for long-term HRQoL. RMI was log transformed (Ln [1 + RMI]) prior to analysis.
Risk Factors Most Strongly Associated With PatientReported Symptoms at 12 Months Post ICU Discharge.
To assess whether consistent associations were also observed when patient symptoms were used in place of HRQoL, we repeated the regression analysis for each of the five patient-reported symptoms (appetite, fatigue, pain, joint stiffness, and breathlessness) at 12 months.
Missing Data. We undertook a complete case analysis. To assess whether cases with missing data were likely to be different from those included, baseline characteristics were compared between missing and included cases.
RESULTS
Of the 240 patients enrolled in the RECOVER (A randomized controlled trial evaluating a rehabilitation complex intervention for patients following intensive care discharge) study, 228, 220, and 218 patients were alive at 3, 6, and 12 months, respectively (study flow diagram in Fig. E1 , Supplemental Digital Content 1, http://links.lww.com/CCM/D206), and HRQoL data were available for 197 of 228 (86%), 165 of 220 (75%), and 155 of 218 (71%) of these survivors. Baseline characteristics are shown in Table 1 . Patients with missing data were similar to included patients in respect of preexisting heath, baseline demographics, and severity of illness (Table E8 , Supplemental Digital Content 1, http://links.lww.com/CCM/D206).
Cohort Level Trajectories of PCS and MCS Between 3 Months and 12 Months After ICU Discharge
Individual patient plots showed marked heterogeneity over time for both HRQoL components (Figs. E2 and E3 , Supplemental Digital Content 1, http://links.lww.com/CCM/D206).
At cohort level, mean PCS was reduced compared with population norms (where population norm is 50 on each scale) at all time points (Fig. 1A and Table 2 ). The PCS increased by a statistically significant but clinically small amount between 3 and 12 months, with an overall change less than the predefined MCID of 5 (mean difference [95% CI], 2.3 (0.6-3.9); p = 0.006). MCS was also reduced compared with population norms but higher than the PCS at each time point. Mean MCS did not change between 3 and 12 months (Fig. 1B and . 1C ). One-hundred one patients (69%) had no clinically significant improvement in MCS (Fig. 1D) . In the sensitivity analysis, 50%, 58%, 70%, and 77% of patients in quartiles 1 (lowest HRQoL), 2, 3, and 4 of PCS at baseline had no clinically important improvement; 44%, 66%, 65%, and 97% of patients in quartiles 1, 2, 3, and 4 of MCS at baseline had no clinically important improvement.
Risk Factors Most Strongly Associated With HRQoL at 6 and 12 Months After ICU Discharge
Adjusted model 1 coefficients (excluding RMI and SGA) at the 6-month time point are shown in Table 3 . Unadjusted coefficients and adjusted model 2 coefficients (including RMI and SGA) are shown in Table E2 (Supplemental Digital Content 1, http://links.lww.com/CCM/D206) (6 mo) and Table E3 (Supplemental Digital Content 1, http://links.lww.com/CCM/ D206) (12 mo). In the adjusted models, a higher comorbidity count was strongly associated with lower (worse) PCS and MCS at 6 and 12 months. Critical illness-related variables were not associated with either PCS or MCS at either time point. Examining other patient characteristics, there was a strong association observed between increasing age and higher (better) MCS at 6 and 12 months. There was also an association between higher social class (higher SIMD quintile [lower deprivation]) and higher (better) MCS at 6 months but not 12 months. In the sensitivity analyses, the inclusion of measures of early post-ICU discharge physical status (RMI and nutrition) did not significantly alter the observed effect sizes.
To illustrate the impact of increasing physical comorbidity on HRQoL trajectory, we plotted HRQoL trajectories according to subgroups of patients with different comorbidity counts prior to ICU admission. This clearly showed that as the numbers of comorbidities present pre-ICU increased, the PCS and MCS were lower during the 12 months following ICU discharge and tended to follow a flatter trajectory indicating lack of improvement ( Fig. 2; and Tables E4-E6, Supplemental lower pain scores. Neither of the acute illness severity factors (APACHE II score or duration of MV) were associated with any of the symptoms. The observed coefficients were not affected by nutrition and baseline RMI when tested in the sensitivity analysis, even though RMI and nutrition were associated with some of the symptom outcomes: Lower RMI (poorer mobility) at baseline was associated with more severe joint stiffness during follow-up. Poorer nutritional status on subjective assessment was associated with higher pain and fatigue scores during follow-up. 
DISCUSSION
We report a secondary analysis of trial data exploring trajectories and determinants of HRQoL and physical symptoms during 12 months of follow-up after critical illness. At cohort level, PCS and MCS were below population means and did not change by a clinically important amount between 3 and 12 months. Specifically, around two thirds of patients showed no clinically important improvement in MCS and PCS (≥ 5 points) between 3 and 6 months, even among the quartiles with lower HRQoL at 3 months. In multivariable analysis, preexisiting comorbidity count emerged as the most important predictor of long-term HRQoL outcome. Patient demographics, measures of critical illness severity, and early postcritical illness physical status were not significant predictors of longterm physical HRQoL once preexisting comorbidity was taken into account. Recovery of physical function was most consistent in patients without pre-ICU comorbidity or with lower comorbidity counts. The almost identical findings for a range of patient reported symptom scores reflecting patient health and well-being provide indirect validation for these findings. Strengths of our study include the use of an externally valid prospectively included sample of ICU survivors from a randomized trial, but caution is still advised when extrapolating to other ICU cohorts. Exposures and outcomes were measured prospectively using valid tools. In particular, comorbidity count was collected prospectively in all patients at the time of enrollment by careful review of medical notes and direct questioning of patient relatives; therefore, the accuracy of the FCI comorbidity is likely to be high. Assessment of illness severity factors was complete and used measures that are known to affect short-term ICU outcomes.
Several limitations should be noted. A power calculation was not conducted making it possible (but unlikely given the small CIs) that small sample size could explain the lack of association between critical illness severity and HRQoL. Missing data may have biased the analysis despite our included patients being similar to those without complete outcome data across all baseline variables measured. SF12v2 was used in preference to the more detailed SF-36 for pragmatic reasons (taking less time and concentration to complete) to reduce attrition bias but may have reduced the resolution of our analysis. The strong relationship between severe subjective malnutrition and less severe physical symptoms is difficult to explain but could relate to the limitations of the SGA measure in edematous post-ICU patients where signs of malnutrition may be masked by edema. Finally, other factors such as social integration and family support in the months following ICU discharge are known to be associated with HRQoL and may have been the cause of (or consequence of) reduced HRQoL in our patients. We were unable to explore this further in our study (26) .
Previous work has shown that ICU survivors have reduced HRQoL with minimal change after ICU, especially after 3 months post hospital discharge (1) (2) (3) . Our data furthers the understanding of patient HRQoL trajectories at population level by showing that between 3 and 12 months, only a minority have clinically important improvement, with the majority remaining static or deteriorating over time. Importantly, these patterns were evident irrespective of the HRQoL quartile at 3 months, with many patients in the lowest quartiles reporting no subsequent improvement. Previous studies have implied that incomplete long-term recovery may be a direct consequences of critical illness, comprising the "PICS." However, most lacked reliable precritical illness comorbidity, HRQoL, or other data to assess the relative contribution of preexisting health to post-ICU outcomes. Orwelius et al (27) used questionnaires administered to ICU patients surviving 6 months from ICU discharge to retrospectively assess pre-ICU health status, with a 59% response rate. Their analysis suggested that preexisting disease was a strong independent determinant of HRQoL outcomes but was potentially subject to recall and response bias. A more recent substudy of patients 70 years old or older, who participated in a larger cohort study of functional recovery but required an ICU admission, explored a range of potential determinants of return to precritical illness functional status. In this analysis, pre-ICU impairments of hearing and vision were strongly associated with poor functional outcome at 6 months, but comorbidity count and ICU-related factors were not (28) . Our prospective study sampled a general mixed ICU population across all adult age groups and provides strong evidence for the importance of pre-ICU comorbidity as a major determinant of post-ICU HRQoL beyond the first 3 months post ICU discharge.
Our findings add to a growing body of research highlighting pre-ICU health as a key determinant of important ICU outcomes including mortality (29) and healthcare resource use (30) in addition to functional recovery and HRQoL. This has implications for future trial design. In trials seeking to improve post-ICU HRQoL for example, more comorbid patients may have limited or no responsiveness to the trial intervention, which could mask important effects in less comorbid groups. In future trials and outcomes research, we believe our data show that careful consideration of preexisting health status is essential when HRQoL or similar patient-centered measures are key long-term outcomes, as has been recently recommended (14) . These factors need to be considered when defining study populations, which baseline data to collect, and how statistical adjustment is undertaken during analyses. Failure to consider these issues may undermine power calculations and mask important clinical effects in less comorbid patients (12) .
CONCLUSIONS
In a prospectively studied sample derived from a post-ICU rehabilitation trial, HRQoL was reduced in ICU survivors. Many patients failed to experience clinically important improvement in HRQoL between 3 and 12 months. Precritical illness comorbidities rather than features of the critical illness were the strongest predictors of survivors' HRQoL and selfreported physical symptoms during the 3-12 months following ICU discharge.
